Literature DB >> 10187787

An inhibitor of p38 mitogen-activated protein kinase prevents insulin-stimulated glucose transport but not glucose transporter translocation in 3T3-L1 adipocytes and L6 myotubes.

G Sweeney1, R Somwar, T Ramlal, A Volchuk, A Ueyama, A Klip.   

Abstract

The precise mechanisms underlying insulin-stimulated glucose transport still require investigation. Here we assessed the effect of SB203580, an inhibitor of the p38 MAP kinase family, on insulin-stimulated glucose transport in 3T3-L1 adipocytes and L6 myotubes. We found that SB203580, but not its inactive analogue (SB202474), prevented insulin-stimulated glucose transport in both cell types with an IC50 similar to that for inhibition of p38 MAP kinase (0.6 microM). Basal glucose uptake was not affected. Moreover, SB203580 added only during the transport assay did not inhibit basal or insulin-stimulated transport. SB203580 did not inhibit insulin-stimulated translocation of the glucose transporters GLUT1 or GLUT4 in 3T3-L1 adipocytes as assessed by immunoblotting of subcellular fractions or by immunofluorescence of membrane lawns. L6 muscle cells expressing GLUT4 tagged on an extracellular domain with a Myc epitope (GLUT4myc) were used to assess the functional insertion of GLUT4 into the plasma membrane. SB203580 did not affect the insulin-induced gain in GLUT4myc exposure at the cell surface but largely reduced the stimulation of glucose uptake. SB203580 had no effect on insulin-dependent insulin receptor substrate-1 phosphorylation, association of the p85 subunit of phosphatidylinositol 3-kinase with insulin receptor substrate-1, nor on phosphatidylinositol 3-kinase, Akt1, Akt2, or Akt3 activities in 3T3-L1 adipocytes. In conclusion, in the presence of SB203580, insulin caused normal translocation and cell surface membrane insertion of glucose transporters without stimulating glucose transport. We propose that insulin stimulates two independent signals contributing to stimulation of glucose transport: phosphatidylinositol 3-kinase leads to glucose transporter translocation and a pathway involving p38 MAP kinase leads to activation of the recruited glucose transporter at the membrane.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10187787     DOI: 10.1074/jbc.274.15.10071

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

Review 1.  Cellular and molecular regulation of cardiac glucose transport.

Authors:  L H Young; D L Coven; R R Russell
Journal:  J Nucl Cardiol       Date:  2000 May-Jun       Impact factor: 5.952

Review 2.  Fluidity of insulin action.

Authors:  Jeffrey S Elmendorf
Journal:  Mol Biotechnol       Date:  2004-06       Impact factor: 2.695

3.  Akt2 phosphorylates ezrin to trigger NHE3 translocation and activation.

Authors:  Harn Shiue; Mark W Musch; Yingmin Wang; Eugene B Chang; Jerrold R Turner
Journal:  J Biol Chem       Date:  2004-11-04       Impact factor: 5.157

4.  Golgin-160 is required for the Golgi membrane sorting of the insulin-responsive glucose transporter GLUT4 in adipocytes.

Authors:  Dumaine Williams; Stuart W Hicks; Carolyn E Machamer; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2006-10-18       Impact factor: 4.138

5.  Metformin enhances insulin signalling in insulin-dependent and-independent pathways in insulin resistant muscle cells.

Authors:  Naresh Kumar; Chinmoy S Dey
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

6.  Pneumocystis cell wall beta-glucans stimulate alveolar epithelial cell chemokine generation through nuclear factor-kappaB-dependent mechanisms.

Authors:  Scott E Evans; Peter Y Hahn; Frances McCann; Theodore J Kottom; Zvezdana Vuk Pavlovic'; Andrew H Limper
Journal:  Am J Respir Cell Mol Biol       Date:  2005-03-03       Impact factor: 6.914

7.  Insulin and dexamethasone induce GLUT4 gene expression in foetal brown adipocytes: synergistic effect through CCAAT/enhancer-binding protein alpha.

Authors:  Rosario Hernandez; Teresa Teruel; Margarita Lorenzo
Journal:  Biochem J       Date:  2003-06-01       Impact factor: 3.857

8.  Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin.

Authors:  June Chunqiu Hou; Jeffrey E Pessin
Journal:  Mol Biol Cell       Date:  2003-07-25       Impact factor: 4.138

9.  Rosiglitazone produces insulin sensitisation by increasing expression of the insulin receptor and its tyrosine kinase activity in brown adipocytes.

Authors:  R Hernandez; T Teruel; M Lorenzo
Journal:  Diabetologia       Date:  2003-11-01       Impact factor: 10.122

10.  p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation.

Authors:  Lee-Anne Stanton; Shalev Sabari; Arthur V Sampaio; T Michael Underhill; Frank Beier
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.